Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-021746

Chairman and CEO bought 19,200 shares at an average $1.11 ($21,364)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-03-26 Purchase +14,200 $1.07 $15,194 10,513,043 D
Niihara Yutaka Chairman and CEO 2020-03-27 Purchase +3,500 $1.21 $4,235 10,516,543 D
Niihara Yutaka Chairman and CEO 2020-03-30 Purchase +1,500 $1.29 $1,935 10,518,043 D
Open-market purchases · 19,200 sh · avg $1.11 · $21,364
Loading xslF345X03/doc4.xml…